Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001703505 | SCV000514913 | likely benign | not provided | 2021-05-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28814775) |
Invitae | RCV000537537 | SCV000637238 | benign | TNF receptor-associated periodic fever syndrome (TRAPS) | 2024-01-12 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001703505 | SCV001157935 | uncertain significance | not provided | 2020-03-10 | criteria provided, single submitter | clinical testing | The TNFRSF1A c.935G>A; p.Arg312Lys variant (rs200900510) is reported in the medical literature in an individual with Behcet disease (Burillo-Sanz 2017). The variant is reported in the ClinVar database (Variation ID: 378735) and is listed in the African population with an allele frequency of 0.35% (69/19,970 alleles, including 1 homozygote) in the Genome Aggregation Database. The arginine at this position is moderately conserved and computational algorithms (PolyPhen-2, SIFT) predict this variant is tolerated. Additionally, there are few known pathogenic variants in this region of the protein (Lobito 2011). Based on this and the increased population frequency in the African population, it is unlikely that this is a high penetrance pathogenic variant. However, we cannot rule out the possibility that this is a low penetrance variant without additional information. Therefore, considering available information, this variant is classified as a variant of uncertain significance. References: Burillo-Sanz S et al. Mutational profile of rare variants in inflammasome-related genes in Behcet disease: A Next Generation Sequencing approach. Sci Rep. 2017 Aug 16;7(1):8453. Lobito AA et al. Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving disease. Trends Mol Med. 2011 Sep;17(9):494-505. |
Illumina Laboratory Services, |
RCV000537537 | SCV001267911 | likely benign | TNF receptor-associated periodic fever syndrome (TRAPS) | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Genome Diagnostics Laboratory, |
RCV002263679 | SCV002543116 | likely benign | Autoinflammatory syndrome | 2021-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001703505 | SCV003917177 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | TNFRSF1A: BP4, BS1 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003317207 | SCV004020771 | uncertain significance | not specified | 2023-06-21 | criteria provided, single submitter | clinical testing | Variant summary: TNFRSF1A c.935G>A (p.Arg312Lys) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00053 in 218402 control chromosomes in the gnomAD database, including 1 homozygotes. c.935G>A has been reported in the literature in individuals affected with Bechet Disease (Burillo-Sanz_2017) and Idiopathic Chronic Pancreatitis (Sofia_2016). These reports do not provide unequivocal conclusions about association of the variant with TNF Receptor-Associated Periodic Fever Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 28814775, 27264265). Seven submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified as benign/likely benign (n=5), VUS (n=1) and likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Department of Immunology, |
RCV000458191 | SCV000503001 | pathogenic | Behcet disease | 2017-02-22 | no assertion criteria provided | case-control |